Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs. Placebo in Cardiac Surgical Patients
NCT05801679Phase 3Completed
- Sponsor
- Endeavor Health
- Start
- Jul 2023
- Primary completion
- Jul 2025
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex in operative procedure, sponsored by Endeavor Health. Started Jul 2023; status: completed.
02
Drugs
Sugammadex
03
Conditions
operative procedure
Beyond the preview
Go deeper on NCT05801679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05801679.